These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11821875)

  • 1. Drug R&D costs queried.
    Birmingham K
    Nat Med; 2002 Feb; 8(2):93. PubMed ID: 11821875
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs of research and patent considerations.
    Vickery BH
    J Androl; 1987; 8(1):S27-32. PubMed ID: 3549653
    [No Abstract]   [Full Text] [Related]  

  • 3. Indirect costs on research grants and contracts.
    Tzagournis M
    Ohio Med; 1991 Dec; 87(12):576-7. PubMed ID: 1766634
    [No Abstract]   [Full Text] [Related]  

  • 4. New estimates of drug development costs.
    Frank RG
    J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149
    [No Abstract]   [Full Text] [Related]  

  • 5. The indirect costs of sponsored research.
    Cooper AD
    Clin Res; 1984 Apr; 32(2):99-105. PubMed ID: 6713806
    [No Abstract]   [Full Text] [Related]  

  • 6. Per diem rates and true costs: apples and oranges.
    Cork LC
    Comp Med; 2002 Feb; 52(1):10-1. PubMed ID: 11900408
    [No Abstract]   [Full Text] [Related]  

  • 7. The price of innovation: new estimates of drug development costs.
    DiMasi JA; Hansen RW; Grabowski HG
    J Health Econ; 2003 Mar; 22(2):151-85. PubMed ID: 12606142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical research in cancer: a time for consensus.
    Oldham RK
    Mol Biother; 1989; 1(5):242-3. PubMed ID: 2619944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cost reductions and their effects on drug research].
    Götte D
    Med Klin (Munich); 2005 Jun; 100(6):309-13. PubMed ID: 15968482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping a medical research project for financial reasons.
    Drueke TB; Descamps-Latscha B; Locatelli F
    Nephrol Dial Transplant; 2003 Oct; 18(10):1982-3. PubMed ID: 13679470
    [No Abstract]   [Full Text] [Related]  

  • 11. Endowments are necessary for museums to thrive.
    Baker DJ; Sabloff JA; Raven PA
    Nature; 2007 May; 447(7143):376. PubMed ID: 17522653
    [No Abstract]   [Full Text] [Related]  

  • 12. Mir for the crystallographers' money.
    Stoddard BL; Strong RK; Arrott A; Farber GK
    Nature; 1992 Nov; 360(6402):293-4. PubMed ID: 1448142
    [No Abstract]   [Full Text] [Related]  

  • 13. Scientific aid to Brazil is strangled by red tape.
    Rehen SK
    Nature; 2004 Apr; 428(6983):601. PubMed ID: 15071574
    [No Abstract]   [Full Text] [Related]  

  • 14. Engineering R&D support by the hospital and university.
    Berkley C
    Med Res Eng; 1970 Dec; 9(6):3-5. PubMed ID: 5501976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sabbatical years].
    Marín Iribarren E
    Med Clin (Barc); 1996 Feb; 106(6):239. PubMed ID: 8667671
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug costs: research and development costs: the great illusion.
    Prescrire Int; 2004 Feb; 13(69):32-6. PubMed ID: 15055226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer research and treatment. When money, morals, and medical science converge.
    Meyer CR
    Minn Med; 1996 Apr; 79(4):5. PubMed ID: 8637493
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost of animal research.
    Lang CM
    Lab Anim (NY); 2009 Oct; 38(10):335-8. PubMed ID: 19773778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug reserach has to be profitable].
    Jacobsen TK
    Nord Med; 1975 Jun; 90(6-7):167-8. PubMed ID: 1153267
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.